Nutex Health Inc (NUTX)

Currency in USD
186.25
-7.91(-4.07%)
Closed·
186.250.00(0.00%)
·
NUTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
186.18194.63
52 wk Range
83.99226.16
Key Statistics
Prev. Close
186.25
Open
194.63
Day's Range
186.18-194.63
52 wk Range
83.99-226.16
Volume
96.19K
Average Volume (3m)
151.93K
1-Year Change
66.3392%
Book Value / Share
63.61
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NUTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
296.17
Upside
+59.02%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Nutex Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 296.17
(+59.02% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Lake Street
Buy333.00+78.79%310.00MaintainNov 09, 2026
Ladenburg Thalmann
Buy336.00+80.40%-New CoverageOct 26, 2026
Freedom Capital
Buy306.00+64.30%280.00MaintainSep 25, 2026
B.Riley
Buy325.00+74.50%290.00MaintainSep 04, 2026
Lake Street
Buy310.00+66.44%235.00MaintainAug 11, 2026

Nutex Health Inc Earnings Call Summary for Q2/2026

  • Nutex Health Q2 EPS of $9.38 beat estimates by 92%, though revenue of $210.8M missed forecasts by 2%; shares surged 10.92% to $168.52.
  • Net income jumped to $65.8M from a $17.7M loss year-ago; gross margin expanded 15.8 points to 67% driven by lower arbitration costs.
  • Arbitration expenses expected to fall 25-30% from normalized levels following May 2026 CMS rule changes and HaloMD contract renegotiation.
  • Company maintains guidance of 3-5 hospital openings annually; three facilities planned for H2 2026 in Arkansas, Texas, and Florida markets.
  • Management projects revenue per visit stable at $4,200; population health division managing 40K patients with new IPAs launching in Dallas and San Antonio in 2027.
Last Updated: 08/08/2026, 12:00 AM
Read Full Transcript

Earnings

Latest Release
Nov 05, 2026
EPS / Forecast
5.71 / 5.96
Revenue / Forecast
217.61M / 214.12M
EPS Revisions
Last 90 days

NUTX Income Statement

Compare NUTX to Peers and Sector

Metrics to compare
NUTX
Peers
Sector
Relationship
P/E Ratio
7.8x4.0x−0.2x
PEG Ratio
0.260.150.00
Price/Book
2.9x3.8x2.6x
Price / LTM Sales
1.6x1.2x2.8x
Upside (Analyst Target)
59.0%21.7%60.9%
Fair Value Upside
Unlock6.9%9.5%Unlock

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.47M21.44%285.07M
Other Institutional Investors
2.57M37.56%499.44M
Public Companies & Retail Investors
2.81M41.00%545.09M
Total
6.85M100.00%1.33B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Topline Capital Partners, LP8.13%556,567108,063
Pertento Partners LLP6.59%451,31087,626

People Also Watch

53.83
MXL
-3.72%
129.80
CRDO
-2.33%
585.57
LITE
-1.78%
859.99
SNDK
-2.99%
164.14
EPAM
+4.67%

FAQ

What Is the Nutex Health (NUTX) Stock Price Today?

The Nutex Health stock price today is 186.25 USD.

What Stock Exchange Does Nutex Health Trade On?

Nutex Health is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Nutex Health?

The stock symbol for Nutex Health is "NUTX."

What Is the Nutex Health Market Cap?

As of today, Nutex Health market cap is 1.28B USD.

What Is Nutex Health's Earnings Per Share (TTM)?

The Nutex Health EPS (TTM) is 23.64.

When Is the Next Nutex Health Earnings Date?

Nutex Health will release its next earnings report on Mar 04, 2027.

From a Technical Analysis Perspective, Is NUTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nutex Health Stock Split?

Nutex Health has split 2 times.

How Many Employees Does Nutex Health Have?

Nutex Health has 1093 employees.

What is the current trading status of Nutex Health (NUTX)?

As of Nov 11, 2026, Nutex Health (NUTX) is trading at a price of 186.25 USD, with a previous close of 186.25 USD. The stock has fluctuated within a day range of 186.18 USD to 194.63 USD, while its 52-week range spans from 83.99 USD to 226.16 USD.

What Is Nutex Health (NUTX) Price Target According to Analysts?

The average 12-month price target for Nutex Health is 296.17 USD, with a high estimate of 336 USD and a low estimate of 200 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +59.02% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.